• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Sparsentan Receives Orphan Drug Designation for IgA Nephropathy

    PR NEWSWIRE

    Renalys Pharma Doses First Patient In Phase III IgA Nephropathy Trial

    PR NEWSWIRE

    Renalys Pharma Raises ¥6.0Bn Series A For Asian Kidney Treatments

    PR NEWSWIRE

    Renalys Submits an IND App for a Ph III Trial of sparsentan for IgA Nephropathy

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.